safety of long-term tildrakizumab for plaque psoriasis: 4-year results from reSURFACE 1. Poster presented at: 28th European Academy of Dermatology and Venereology Congress
home / authors / safety-of-long-term-tildrakizumab-for-plaque-psoriasis-4-year-results-from-resurface-1-poster-presented-at-28th-european-academy-of-dermatology-and-venereology-congress